These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4145253)

  • 1. Action of isoprenaline and -blocking agents on stroke volume regulation.
    Fenyvesi T; Hadházy P
    Eur J Pharmacol; 1973 Apr; 22(1):105-8. PubMed ID: 4145253
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenoceptor blocking drugs at maximum beta-blockade in relation to dose and plasma concentration.
    Gugler R; Krist R; Raczinski H; Höffgen K; Boden G
    Cardiology; 1979; 64 Suppl 1():20-4. PubMed ID: 42486
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
    Jaillon P; Hecklé J; Weissenburger J; Cheymol G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological characterisation of -receptor blocking agents.
    Saameli K
    Jpn J Pharmacol; 1972; 22():Suppl22:13. PubMed ID: 4403917
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative effects of propranolol, pindolol, and practolol after excision of the sinoatrial node in dogs.
    Fabry-Delaigue R; Duchêne-Marullaz P; Lemaire P; Kantelip JP
    J Cardiovasc Pharmacol; 1981; 3(5):1082-92. PubMed ID: 6168853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria.
    Hattori K; Suzuki J; Hosohata Y; Ohnuki T; Nakamura T; Watanabe K; Muramatsu I; Nagatomo T
    Pharmacology; 1999 Oct; 59(4):183-91. PubMed ID: 10474078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs.
    Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S
    Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of 3 beta adrenolytics on plasma renin hyperactivity induced by isoprenaline in the anesthtized dog. Contribution to its mechanism of action].
    Van den Driessche J; Lacroix P; Quiniou P; Linée Ph; Delamaire J; Le Clec'h ; Patay M
    C R Seances Soc Biol Fil; 1974; 168(4-5):595-602. PubMed ID: 4156186
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the beta receptor blocking properties of two analogs of dichloroisoproterenol (DCI).
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):123-33. PubMed ID: 4146700
    [No Abstract]   [Full Text] [Related]  

  • 20. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
    Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T
    Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.